GSK has made known the delivery of its cutting-edge oncology treatment Jemperli (dostarlimab) and Zejula (niraparib) in India, a considerable move to elevate the provision of precision cancer treatments.
Bayer has announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for gadoquatrane, an investigational macrocyclic gadolinium-based contrast agent
If not properly handled, shifting GST rates for medical equipment could affect domestic competitiveness, the Association of Indian medical Device Industry (AiMeD) said. The majority of devices are now subject to 12% GST, whilst inputs are subject to
Shilpa Medicare Limited has finalized a definitive agreement with Pharmaceutical Industries & Biological Products (PPI), a leading enterprise in Saudi Arabia, through its subsidiary Koanna International FZ LLC
The largest consumer electronics company in India, Samsung, has announced the arrival of its next-generation mobile CT product line in India in partnership with NeuroLogica, a division of Samsung Electronics Co., Ltd.
Biocon has announced that its wholly owned subsidiary, Biocon Pharma Limited has received Tentative Approval from the United States Food and Drug Administration (USFDA)
The Food Safety and Standards Authority of India (FSSAI) is planning to release an advisory to restaurants and hotels to include labels in their outlets regarding key ingredients like sugar and oil in their dishes.
Dr. Reddy's Laboratories Ltd. has marked a milestone in the Indian pharmaceutical industry, putting forth Linaclotide, the new first-in-class Guanylate Cyclase-C (GC-C) agonist, in adults with chronic constipation. Under the brand name Colozo, the dr
Terumo India, the Indian subsidiary of Terumo Corporation (TSE: 4543), a global leader in medical technology, has launched Terufusion Advanced Infusion Systems in India for the first time.
Merck, known as MSD outside the U.S. and Canada, will present new clinical trial and outcomes research results at the European Society of Cardiology Congress (ESC) 2025 in Madrid, Spain, from August 29 – September 1. The statistics emphasize Merck’s
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")